US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors
NCT ID: NCT03452644
Last Updated: 2023-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
350 participants
OBSERVATIONAL
2018-09-20
2020-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incisional Biopsy Versus Core-needle Biopsy in Bone Tumors Analysis
NCT07113301
Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies
NCT01384357
Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)
NCT02834585
Determination of Longus Colli Muscle Thickness by Ultrasonography
NCT05108103
EUS- and US- Guided Biopsy for Pancreatic Lesion
NCT07138976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary aim of our work is to evaluate the diagnostic yield of US-CNB. The secondary aim is to exploit all the imaging data conventionally available at a Sarcoma Center before a biopsy on a soft tissue mass, to build a multiparametric model and score of prediction of malignancy, and eventually of biological behavior - grading.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Ortopedico Rizzoli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alberto Bazzocchi
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alberto Bazzocchi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
The Rizzoli Ortopaedic Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rizzoli Orthopaedic Institute
Bologna, Bo, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Softbiopsy@IOReco
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.